Drug
Endothelin-1
Endothelin-1 is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown133%
completed133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05653973Early Phase 1
Prenatal Aspirin and Postpartum Vascular Function
NCT00745693Not Applicable
The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin
NCT02906085Not Applicable
Endothelin-1 as a Potential Trigger of Migraine Aura
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3